全科医学

订阅

MedSci主页 / 所有栏目 / 全科医学

MedSci资讯2.3版更新

2013-03-30 MedSci MedSci原创

MedSci资讯手机APP

MedSci资讯（手机应用，也是MedSci客户端）全面更新 大家可以登陆到这里下载：http://www.medsci.cn/m/ipad.asp ，也可以到应用商店中搜索“MedSci资讯”，即可下载。此次2.3更新主要针对iphone版。iPad，Androil版更新随后进行。 2.3版进行了较大更新，主要根据大量用户的反馈，不断改进，包括如下功能： iphone部分 新增若干功能+

MedSci资讯（手机应用，也是MedSci客户端）全面更新

大家可以登陆到这里下载：https://www.medsci.cn/m/ipad.asp ，也可以到应用商店中搜索“MedSci资讯”，即可下载。此次2.3更新主要针对iphone版。iPad，Androil版更新随后进行。

2.3版进行了较大更新，主要根据大量用户的反馈，不断改进，包括如下功能：

iphone部分 新增若干功能

+ 注册和登录功能(medsci.cn帐号直接登录)
+ 评论功能（注册登录用户回复增加积分，也可匿名评论）
+ 夜间浏览模式，提高夜间浏览效果

+ 点击过的新闻，增加提示，颜色自动变淡
+ 有新回复提示（点击过的新闻），可以了解哪些新闻被评论过，您也可以参与评论
+ 新闻内字体统一（绝大部分）

同时还能自定义栏目，可以选择与您学科相关的栏目进行浏览。

接下来，还会增加分享功能。

感谢大家的支持！

MedSci开发团队

 

iPhone Screenshot 1 iPhone Screenshot 2
 
iPad版
 
iPad Screenshot 1
 
 

评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2085083, encodeId=de96208508399, content=<a href='/topic/show?id=26651150528' target=_blank style='color:#2F92EE;'>#MedSci资讯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11505, encryptionId=26651150528, topicName=MedSci资讯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat May 25 05:54:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605909, encodeId=c4401605909ab, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Apr 01 00:54:00 CST 2013, time=2013-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5566, encodeId=aa17556681, content=试用一下，感觉不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Richard, createdTime=Sat Mar 30 22:58:00 CST 2013, time=2013-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5565, encodeId=cae65565fa, content=很好用，下载了，多谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jerry, createdTime=Sat Mar 30 20:59:00 CST 2013, time=2013-03-30, status=1, ipAttribution=)]
    2013-05-25 qidongfanjian

    #MedSci资讯#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2085083, encodeId=de96208508399, content=<a href='/topic/show?id=26651150528' target=_blank style='color:#2F92EE;'>#MedSci资讯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11505, encryptionId=26651150528, topicName=MedSci资讯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat May 25 05:54:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605909, encodeId=c4401605909ab, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Apr 01 00:54:00 CST 2013, time=2013-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5566, encodeId=aa17556681, content=试用一下，感觉不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Richard, createdTime=Sat Mar 30 22:58:00 CST 2013, time=2013-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5565, encodeId=cae65565fa, content=很好用，下载了，多谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jerry, createdTime=Sat Mar 30 20:59:00 CST 2013, time=2013-03-30, status=1, ipAttribution=)]
    2013-04-01 ms3994565386320060

    #Med#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2085083, encodeId=de96208508399, content=<a href='/topic/show?id=26651150528' target=_blank style='color:#2F92EE;'>#MedSci资讯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11505, encryptionId=26651150528, topicName=MedSci资讯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat May 25 05:54:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605909, encodeId=c4401605909ab, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Apr 01 00:54:00 CST 2013, time=2013-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5566, encodeId=aa17556681, content=试用一下，感觉不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Richard, createdTime=Sat Mar 30 22:58:00 CST 2013, time=2013-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5565, encodeId=cae65565fa, content=很好用，下载了，多谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jerry, createdTime=Sat Mar 30 20:59:00 CST 2013, time=2013-03-30, status=1, ipAttribution=)]
    2013-03-30 Richard

    试用一下，感觉不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2085083, encodeId=de96208508399, content=<a href='/topic/show?id=26651150528' target=_blank style='color:#2F92EE;'>#MedSci资讯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11505, encryptionId=26651150528, topicName=MedSci资讯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat May 25 05:54:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605909, encodeId=c4401605909ab, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Apr 01 00:54:00 CST 2013, time=2013-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5566, encodeId=aa17556681, content=试用一下，感觉不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Richard, createdTime=Sat Mar 30 22:58:00 CST 2013, time=2013-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5565, encodeId=cae65565fa, content=很好用，下载了，多谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jerry, createdTime=Sat Mar 30 20:59:00 CST 2013, time=2013-03-30, status=1, ipAttribution=)]
    2013-03-30 jerry

    很好用，下载了，多谢

    0